Steward Partners Investment Advisory’s TherapeuticsMD TXMD Stock Holding History

Steward Partners Investment Advisory’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$71	Hold	35	–	–	﹤0.01%	4354
2025 Q4	$57	Hold	35	–	–	﹤0.01%	4247
2025 Q3	$38	Sell	35 -1	-3%	-$1	﹤0.01%	4218
2025 Q2	$42	Buy	36 +1	+3%	+$1	﹤0.01%	4065
2025 Q1	$32	Buy	+35	New	+$35	﹤0.01%	3975
2023 Q3	–	Sell	-11	Closed	-$45	–	3446
2023 Q2	$45	Hold	11	–	–	﹤0.01%	3286
2023 Q1	$41	Sell	11 -2	-15%	-$10	﹤0.01%	3276
2022 Q4	$73	Hold	13	–	–	﹤0.01%	3307
2022 Q3	$0	Hold	13	–	–	﹤0.01%	3385
2022 Q2	$0	Buy	13 +1	+8%	+$10	﹤0.01%	3374
2022 Q1	$0	Buy	12 +1	+9%	+$16	﹤0.01%	3382
2021 Q4	$0	Hold	11	–	–	﹤0.01%	3323
2021 Q3	$0	Sell	11 -4	-27%	-$178	﹤0.01%	3336
2021 Q2	$1K	Hold	15	–	–	﹤0.01%	6996
2021 Q1	$1K	Hold	15	–	–	﹤0.01%	3311
2020 Q4	$1K	Sell	15 -13	-46%	-$888	﹤0.01%	2821
2020 Q3	$2K	Hold	28	–	–	﹤0.01%	2606
2020 Q2	$2K	Hold	28	–	–	﹤0.01%	2498
2020 Q1	$1K	Hold	28	–	–	﹤0.01%	2428
2019 Q4	$3K	Hold	28	–	–	﹤0.01%	2380
2019 Q3	$5K	Hold	28	–	–	﹤0.01%	2260
2019 Q2	$3K	Buy	+28	New	+$5.02K	﹤0.01%	2384
2018 Q4	–	Sell	-24	Closed	-$8K	–	2065
2018 Q3	$8K	Hold	24	–	–	﹤0.01%	1984
2018 Q2	$7K	Buy	+24	New	+$7.33K	﹤0.01%	1895
2018 Q1	–	Sell	-36	Closed	-$10K	–	2340
2017 Q4	$10K	Hold	36	–	–	﹤0.01%	1355
2017 Q3	$9K	Sell	36 -45	-56%	-$13K	﹤0.01%	1147
2017 Q2	$21K	Buy	81 +57	+238%	+$14.3K	﹤0.01%	854
2017 Q1	$8K	Buy	+24	New	+$7.43K	﹤0.01%	1009

Other funds holding TXMD

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $273M AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Steward Partners Investment Advisory's TXMD Position: Q1 2026 in Review

Steward Partners Investment Advisory held its TherapeuticsMD (TXMD) position steady in Q1 2026 at 35 shares worth $71. The position accounts for ﹤0.01% of the portfolio, ranked #4354.

Steward Partners Investment Advisory first reported a position in TXMD in Q1 2017 and has held it in 28 quarters since. The position peaked at $21K in Q2 2017. 49 funds tracked by Wall St. Rank hold TXMD as of Q1 2026.

Steward Partners Investment Advisory held 35 shares of TherapeuticsMD worth $71 as of Q1 2026.
Steward Partners Investment Advisory left its TherapeuticsMD share count unchanged in Q1 2026.
TherapeuticsMD made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #4354 holding.
Steward Partners Investment Advisory first reported a position in TherapeuticsMD in Q1 2017 and has held it in 28 quarters since.
Steward Partners Investment Advisory's TherapeuticsMD position peaked at $21K in Q2 2017.
49 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.